1. Home
  2. TTD vs RDY Comparison

TTD vs RDY Comparison

Compare TTD & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Trade Desk Inc.

TTD

The Trade Desk Inc.

HOLD

Current Price

$22.43

Market Cap

13.0B

Sector

Technology

ML Signal

HOLD

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

HOLD

Current Price

$13.24

Market Cap

11.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTD
RDY
Founded
2009
1984
Country
United States
India
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
11.6B
IPO Year
2016
2001

Fundamental Metrics

Financial Performance
Metric
TTD
RDY
Price
$22.43
$13.24
Analyst Decision
Buy
Strong Buy
Analyst Count
34
1
Target Price
$46.22
$16.90
AVG Volume (30 Days)
14.2M
2.5M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
0.52%
EPS Growth
15.38
N/A
EPS
0.08
N/A
Revenue
$2,896,284,000.00
N/A
Revenue This Year
$13.94
$7.72
Revenue Next Year
$12.61
$3.50
P/E Ratio
$26.64
$18.67
Revenue Growth
18.47
N/A
52 Week Low
$19.74
$12.77
52 Week High
$91.45
$16.17

Technical Indicators

Market Signals
Indicator
TTD
RDY
Relative Strength Index (RSI) 44.88 44.81
Support Level $21.41 $12.90
Resistance Level $24.59 $14.21
Average True Range (ATR) 1.05 0.26
MACD 0.08 0.00
Stochastic Oscillator 42.58 31.82

Price Performance

Historical Comparison
TTD
RDY

About TTD The Trade Desk Inc.

The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: